Adverse Drug Reactions 20.11.23 Flashcards

1
Q

Define adverse drug reaction (ADR)?

A

A response to a medicinal product, or combination of medicinal products, which is noxious and unintended (MHRA 2015)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are 4 wider impacts of ADRs on patients?

A

Reduced Quality of life

Poor compliance

Reduced confidence in clinicians and the healthcare system

Unnecessary investigations or treatments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are 4 wider impacts of ADRs on the NHS?

A

Increased hospital admissions

Longer hospital stays

GP appointments

Inefficient use of medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How are ADRs classified (e.g. type ……. Of ADR)?

A

A - augmented
B - bizarre
C - chronic
D - delayed
E - end of use/withdrawal
F - failure of treatment
G - genetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What’s the most common type of ADR?

A

Type A ADR (80% of ADRs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Are type A ADRs often life threatening?

A

Often not life threatening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What effect do type A ADRs have

A

Exaggerated effect of drugs pharmacology at a therapeutic dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Are ADRs does dependent and reversible? If so, how?

A

Exaggerated effect of drugs pharmacology at a therapeutic dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Example of Type A ADR

A

AKI with ACE inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Are type B ADRs life threatening?

A

Yes - can cause serious illness or mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

4 features of type B ADRs

A

Not related to pharmacology of drug

Not dose related

Can cause serious illness or mortality

Symptoms do not always resolve upon stopping drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

1 type C ADR features

A

ADRs that continue after the drug has been stopped

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

1 type D ADR features

A

ADRs that become apparent some time after stopping the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

1 type E ADR features

A

ADR develops after the drug has been stopped

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

3 type F ADR features

A

Unexpected treatment failure

Could be due to drug-drug interaction or drug-food interaction

Poor compliance with administration instructions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

1 type G ADR features

A

Drug causes irreversible damage to genome

17
Q

What is another way (other than ABCDEFG) to classify ADRs?

A

DoTS

Do - Dose-relatedness
T - Timing
S - Susceptibility

18
Q

Describe the ‘dose-relatedness’ part of DoTS way of classifying ADRs

A

Hypersusceptibility: ADRs at subtherapeutic doses (eg anaphylaxis with penicillins)

Collateral effects (side effects): ADRs at therapeutic doses (eg hypokalaemia with loop diuretic)

Toxic effects: ADRs at subpratherapeutic doses (eg liver damage with paracetamol)

19
Q

Describe the ‘timing’ part of DoTS way of classifying ADRs

A

Can be time independent or time dependant.

Time independent: ADRs which can develop during any time during treatment (often due to clinical changes in the patient)

Time dependent:

Rapid - due to rapid administration

First dose - first dose only

Early - Occur early during treatment but resolve as treatment progresses

Intermediate - Occur after some delay

Late - Risk increases with prolonged or repeated exposure

Delayed - occurs some time after exposure or after drug withdrawal

20
Q

Describe the ‘susceptibility’ part of DoTS way of classifying ADRs:

What 4 certain patient groups/populations may have a specific susceptibility to ADRs from a drug?

A

Age (anticholinergics in elderly patients)

Gender (metoclopramide in females)

Disease states (eg diclofenac in CVD)

Physiological states (eg phenytoin in pregnancy)